A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Incyte Corporation